Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study

BACKGROUND AND OBJECTIVES: Natalizumab reduces the relapse rate and magnetic resonance imaging activity in patients with Relapsing-Remitting Multiple Sclerosis (RRMS). So far the influence of natalizumab on cognitive functions and fatigue in MS remains uncertain. The aim of this prospective, open-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Iaffaldano, Pietro, Viterbo, Rosa Gemma, Paolicelli, Damiano, Lucchese, Guglielmo, Portaccio, Emilio, Goretti, Benedetta, Direnzo, Vita, D'Onghia, Mariangela, Zoccolella, Stefano, Amato, Maria Pia, Trojano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338465/
https://www.ncbi.nlm.nih.gov/pubmed/22558238
http://dx.doi.org/10.1371/journal.pone.0035843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338465/
https://www.ncbi.nlm.nih.gov/pubmed/22558238
http://dx.doi.org/10.1371/journal.pone.0035843

Ejemplares similares